Physician profile
Kelsey Olson
NPI 1861084725
$1,663.63
in general payments reported to CMS, 2019-2025
19 companies · $743 in 2025
The $743 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.70 · 2023: $64.00 · 2024: $816 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $936.23 | 2023-2025 | |
| Pfizer INC. | $161.92 | 2024-2025 | |
| Lilly USA, LLC | $79.19 | 2024-2025 | Emgality, Kisunla, Amyvid |
| Neurocrine Biosciences, INC. | $62.34 | 2024-2025 | Ingrezza |
| Ucb, INC. | $51.10 | 2025 | Briviact, Zilbrysq |
| Acadia Pharmaceuticals INC | $49.68 | 2025 | Nuplazid |
| Argenx US, INC. | $44.67 | 2024-2025 | Vyvgart, Vyvgart Hytrulo |
| Catalyst Pharmaceuticals, INC. | $40.60 | 2025 | |
| Jazz Pharmaceuticals INC. | $39.18 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $31.70 | 2025 | Wainua |
| Takeda Pharmaceuticals U.S.A., INC. | $26.94 | 2024 | Hyqvia |
| Sanofi Pasteur INC. | $25.87 | 2023 | |
| Tonix Medicines, INC. | $22.49 | 2025 | Zembrace Symtouch |
| Glaxosmithkline, LLC. | $20.44 | 2024 | Shingrix, Arexvy |
| Idorsia Pharmaceuticals US INC | $17.00 | 2024 | Quviviq |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $14.84 | 2021 | |
| Hologic Sales and Service, LLC | $14.34 | 2021 | |
| Novo Nordisk INC | $13.58 | 2023 | Ozempic, Rybelsus |
| Dexcom, INC. | $11.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.